Company profile

Vicarious Surgical

Surgical AI & RoboticsPublic stage

Company profile

About Vicarious Surgical

A next-generation medical robotics company designing technology for minimally invasive surgery with a focus on abdominal access and teleoperation.

Company description Vicarious Surgical official website

Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at Vicarious Surgical?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Abdominal surgery
  • Minimally invasive surgical procedures

Who it serves

  • Health Systems
  • Hospitals
  • Surgeons

Deployment & integration

On Premise deployment with recorded integration context.

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

Successful in-vivo porcine lab (January 2026), strategic software execution partnership (December 2025), appointment of Joseph Doherty as Chairman of the Board (September 2025), Stephen From appointed CEO (July 2025), Sarah Romano appointed CFO (March 2025)

Partnerships

Recorded partners

  • UMass Memorial Medical Center

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Vicarious Surgical Robotic System

Single-port robotic surgical system with 1.5cm incision for minimally invasive abdominal surgery

Device · On PremiseCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

Dynamic primitives in constrained action: systematic changes in the zero-force trajectory.

Journal of neurophysiology · Jan 1, 2024

The Amigo™ Remote Catheter System: From Concept to Bedside.

The Journal of innovations in cardiac rhythm management · Aug 1, 2017

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Incision size reduction

Single port requiring 1.5 cm incision (as low as 1.2 cm capable) compared to traditional multi-port approaches

Minimized risk of complications

Through minimally invasive approach

Shortened healing time

Potential benefit of minimally invasive surgery

UMass Memorial Medical Center

Collaboration for surgical robotics development and testing

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Vicarious Surgical

Recent articles published on Vicarious Surgical's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Surgical AI & Robotics

Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon